Schedule 13G ownership disclosure

NEOLEUKIN THERAPEUTICS INC

Security class unavailable · CUSIP: 64049K104

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
860,619
Percent of class
2.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-22-000163
Form type
SC 13G/A
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
Feb 14, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub